when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

mRNA Therapeutic · news · pharmadog

← back to mRNA Therapeutic

News · mRNA Therapeutic

173 stories

Aug 19, 26Moderna and Merck cancer vaccine returns ‘landmark’ result in melanomabiopharma dive

Aug 19, 26Dissecting Chinese trial strategy in wake of deathsstat

Aug 19, 26Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccineendpoints

Aug 19, 26STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trialstat

Aug 18, 26Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval pushfiercebiotech

Aug 17, 26FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vaxbiopharma dive

Aug 14, 26Capricor soars on potential FDA review extension, filing amendmentsbiospace

Aug 12, 26Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO saysstat

Aug 12, 26BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectationsbiospace

Aug 12, 26With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug developmentbiospace

Aug 11, 26Medicaid will stop paying for some gender-affirming care for transgender minorsstat

Aug 11, 26STAT+: Trump’s vaccine pivot overshadows food rulestat

Aug 11, 26Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugsfiercebiotech

Aug 10, 26Trump returns to controversial vaccine policy with order questioning childhood schedulestat

Aug 10, 26STAT+: Ban prior auth? And hospitals cut jobsstat

Aug 10, 26Opinion: We prepared for Ebola — but not this Ebolastat

Aug 10, 26Opinion: We prepared for Ebola — but not this Ebolastat

Aug 10, 26Sobi pens $580M deal for Innate’s skin cancer drug ahead of phase 3 pushfiercebiotech

Aug 7, 26Opinion: Fauci doesn’t have the answers on Covid’s origins. China doesstat

Aug 7, 26Is the biotech capital of the world moving?stat

Aug 7, 26STAT+: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California?stat

Aug 7, 26Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attackstat

Aug 7, 26Opinion: AI won’t enhance physician autonomy. It will further diminish itstat

Aug 6, 26Third time’s the charm for Replimune as melanoma drug earns FDA greenlightbiospace

Aug 6, 26STAT+: FDA approves Replimune melanoma drug previously rejected twicestat

Aug 6, 26Chutes & Ladders—BioNTech brings in Sobi CEOfiercebiotech

Aug 6, 26STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug developmentstat

Aug 6, 26STAT+: Two FDA approvals — a new drug and a new vaccinestat

Aug 6, 26U.S. moves to shut a Kentucky organ donation group, citing safety failuresstat

Aug 6, 26Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid responsestat

← prevpage 4 of 6next →